Antidote
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Antidote is a legal tech company that provides an AI-powered billing compliance platform designed for law firms to automate time entry compliance, reduce revenue leakage, and streamline billing operations.
Sector
Enterprise Software
Verticals
Legal Tech, Compliance & Risk, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote Comparables
Compare Antidote with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PointOne | 88% | |
| Ayora Technologies | 83% | |
| Billables AI | 75% |
Antidote Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2026 |
Key People
Founding team and executive leadership
Antidote Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lakestar | Seed |
| The LegalTech Fund | Seed |
| Concept Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Mar 23, 2026
Grew 33% QoQ from 9 to 12 employees.
Antidote Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antidote's valuation, stock price, and market status.
Is Antidote a public or private company?
Antidote is a private company.
What is the current stock price of Antidote?
Antidote is a private company with no public stock price. No recent secondary market data is available.
How much is Antidote worth (valuation)?
Valuation information for Antidote is not publicly available.
Can I buy Antidote stock?
Antidote shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antidote's last funding round?
Antidote's most recent funding round was Seed on January 21, 2026.
Who are the main investors in Antidote?
Key investors in Antidote include Amadeus Capital Partners, Lakestar, Smedvig Capital, LBO France, Octopus Investments.
Will Antidote IPO soon?
No public IPO plans have been announced for Antidote.
How can I track Antidote secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antidote's secondary market activity and sign up for updates.